Cargando…
Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463738/ https://www.ncbi.nlm.nih.gov/pubmed/28768688 http://dx.doi.org/10.2337/dc17-0403 |
_version_ | 1783410805045198848 |
---|---|
author | Lyons, Sarah K. Hermann, Julia M. Miller, Kellee M. Hofer, Sabine E. Foster, Nicole C. Rami-Merhar, Birgit M. Aleppo, Grazia Seufert, Jochen DiMeglio, Linda A. Danne, Thomas Maahs, David M. Holl, Reinhard W. |
author_facet | Lyons, Sarah K. Hermann, Julia M. Miller, Kellee M. Hofer, Sabine E. Foster, Nicole C. Rami-Merhar, Birgit M. Aleppo, Grazia Seufert, Jochen DiMeglio, Linda A. Danne, Thomas Maahs, David M. Holl, Reinhard W. |
author_sort | Lyons, Sarah K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6463738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-64637382019-04-26 Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries Lyons, Sarah K. Hermann, Julia M. Miller, Kellee M. Hofer, Sabine E. Foster, Nicole C. Rami-Merhar, Birgit M. Aleppo, Grazia Seufert, Jochen DiMeglio, Linda A. Danne, Thomas Maahs, David M. Holl, Reinhard W. Diabetes Care e-Letters: Observations American Diabetes Association 2017-10 2017-08-02 /pmc/articles/PMC6463738/ /pubmed/28768688 http://dx.doi.org/10.2337/dc17-0403 Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | e-Letters: Observations Lyons, Sarah K. Hermann, Julia M. Miller, Kellee M. Hofer, Sabine E. Foster, Nicole C. Rami-Merhar, Birgit M. Aleppo, Grazia Seufert, Jochen DiMeglio, Linda A. Danne, Thomas Maahs, David M. Holl, Reinhard W. Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title | Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title_full | Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title_fullStr | Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title_full_unstemmed | Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title_short | Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries |
title_sort | use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and t1d exchange registries |
topic | e-Letters: Observations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463738/ https://www.ncbi.nlm.nih.gov/pubmed/28768688 http://dx.doi.org/10.2337/dc17-0403 |
work_keys_str_mv | AT lyonssarahk useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT hermannjuliam useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT millerkelleem useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT hofersabinee useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT fosternicolec useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT ramimerharbirgitm useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT aleppograzia useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT seufertjochen useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT dimegliolindaa useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT dannethomas useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT maahsdavidm useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries AT hollreinhardw useofadjuvantpharmacotherapyintype1diabetesinternationalcomparisonof49996individualsintheprospectivediabetesfollowupandt1dexchangeregistries |